This Week in Nature

In Nature this week, two public affairs and technology experts sound off on the rise of the genome-editing technology CRISPR and perceptions about how it should be used and regulated. In the first comment piece, Todd Kuiken of the Wilson Center's Synthetic Biology Project argues against worries that do-it-yourself biologists may misuse CRISPR and that there is "no a priori reason to expect this community to cause more harm through using it than anyone else."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.